Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Cash & Current Investments: 2016-2025

Historic Cash & Current Investments for cbdMD (YCBD) over the last 9 years, with Sep 2025 value amounting to $2.3 million.

  • cbdMD's Cash & Current Investments fell 7.80% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year decrease of 16.57%. This contributed to the annual value of $2.3 million for FY2025, which is 7.80% down from last year.
  • As of Q3 2025, cbdMD's Cash & Current Investments stood at $2.3 million, which was up 113.41% from $1.1 million recorded in Q2 2025.
  • cbdMD's 5-year Cash & Current Investments high stood at $27.4 million for Q3 2021, and its period low was $1.1 million during Q2 2025.
  • For the 3-year period, cbdMD's Cash & Current Investments averaged around $2.0 million, with its median value being $2.0 million (2024).
  • Per our database at Business Quant, cbdMD's Cash & Current Investments spiked by 81.52% in 2021 and then crashed by 88.01% in 2023.
  • Over the past 5 years, cbdMD's Cash & Current Investments (Quarterly) stood at $20.7 million in 2021, then crashed by 78.97% to $4.4 million in 2022, then plummeted by 65.43% to $1.5 million in 2023, then skyrocketed by 30.92% to $2.0 million in 2024, then dropped by 7.80% to $2.3 million in 2025.
  • Its Cash & Current Investments stands at $2.3 million for Q3 2025, versus $1.1 million for Q2 2025 and $1.8 million for Q1 2025.